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Background: Juvenile xanthogranuloma (JXG) is a benign idiopathic cutaneous granulomatous tumor occurring
primarily in infants less than 1 year old, and less commonly found in older children and adults. To date, however,
there have been no reports of patients aged >50 years with cornealscleral JXG without limbal involvement. We
describe here a 58-year-old woman with subconjunctival JXG without limbal involvement.
Case presentation: A 58-year-old female was referred for evaluation of a subconjunctival mass in her left eye, found
incidentally 2 weeks earlier. Examination revealed a protruding yellow-orange subconjunctival mass just below the
6-o’clock limbus of her left eye, measuring 6.0 × 4.5 mm, but not extending into the cornea. The overlying conjunctival
epithelium was intact, and a feeding vessel was observed between the mass and the episclera. The subconjunctival
lesion was excised under local anesthesia, by dissecting the mass from the overlying conjunctiva and underlying sclera.
The conjunctiva was reattached to the sclera without creating a bare area. Hematoxylin and eosin-stained sections
showed that the mass was a mixed inflammatory lesion containing dense infiltrations of epithelioid histiocytes with
foamy cytoplasm, lymphocytes, and plasma cells, as well as multinucleated Touton giant cells with the characteristic
circumferential ring of nuclei. Immunohistochemical staining showed that the lesion was positive for the macrophage
marker CD68 and negative for the Langerhans cell markers S-100 protein and CD1a, indicating that the lesion was a
xanthogranuloma. The patient has been followed up for 12-months without recurrence.
Conclusions: JXG can occur as a solitary subconjunctival mass even in older adults, and immunohistochemistry is
useful in differential diagnosis. Simple excision with careful dissection may be effective for subconjunctival JXG.
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Juvenile xanthogranuloma (JXG) is a benign idiopathic
cutaneous granulomatous tumor occurring primarily in
infants less than 1 year old, and less commonly found in
older children and adults [1,2]. Cutaneous lesions appear
as orange-red macules or papules, predominantly over
the face, neck, and upper trunk and usually resolve
spontaneously over 1 to 5 years [1]. Ocular JXG occurs
up to 10% of patients with JXG, usually as a solitary
mass in the iris. This can cause spontaneous hyphema
or secondary glaucoma, threatening the vision of affected
individuals [1,3]. Ocular JXG may also involve the eyelid,
corneoscleral limbus, conjunctiva, orbit, retina, choroid,
disc, and optic nerve [2,4,5].* Correspondence: lineblue@hanmail.net
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unless otherwise stated.Although JXG mainly occurs in infants, it is occasionally
encountered in adults, with several adults reported with
corneoscleral limbal JXG [6-11]. To date, however, there
have been no reports of patients older than 50 years of age
with corneoscleral JXG without limbal involvement. Here,
we describe a 58-year-old woman who presented with
subconjunctival JXG without limbal involvement.
Case presentation
This study has been granted an exemption from requiring
ethics approval by the Institutional Review Board of the
Ethics Committee of Asan Medical Center, Seoul, Korea,
under the tenets of the Helsinki declaration.
A 58-year-old female was referred for evaluation of a
subconjunctival mass in the left eye found incidentally
2 weeks earlier. The patient’s medical history was unre-
markable, with no individual or family history of ocular
disease. Ocular examination showed a protruding yellow-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Anterior segment findings. (A) A yellow-orange subconjunctival mass with feeding vessels below the 9 o/c limbus. The overlying
conjunctiva was intact. (B) Twelve months postoperatively, there was no evidence of recurrence.
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limbus of her left eye, measuring 6.0 × 4.5 mm without
extending into the cornea (Figure 1A). The overlying
conjunctival epithelium was intact, and a feeding vessel
was observed between the mass and the episclera.
Orbital computed tomography with enhancement and
ocular examination showed no evidence of skin, periorbital,
iris, or posterior segment involvement. Her left eye had an
uncorrected visual acuity of 20/25, an intraocular pressure
of 14 mmHg, and an autokeratometric cylinder of− 0.5 D
with an axis of 155 degrees.
The subconjunctival lesion was excised under local
anesthesia by dissecting the mass from the overlying
conjunctiva and underlying sclera. The conjunctiva was
reattached to the sclera without creating a bare area.
Hematoxylin and eosin-stained sections showed that
the mass was a mixed inflammatory lesion, with dense
infiltration of epithelioid histiocytes with foamy cytoplasm,
lymphocytes, and plasma cells, as well as multinucleated
Touton giant cells characterized by a circumferential ring
around the nuclei (Figure 2). Immunohistochemical stain-
ing showed that the lesion was positive for the macro-
phage marker CD68 and negative for the Langerhans cell
markers S-100 protein and CD1a, indicating that the
lesion was a xanthogranuloma (Figure 3).
The patient has been followed up closely for 12-months,
with no sign of recurrence (Figure 1B).Figure 2 Histological findings. (A) Hemotoxylin-eosin staining, showing a
histiocytes with foamy cytoplasm, lymphocytes, plasma cells, and multinu
the characteristic circumferential ring of nuclei (arrow), surrounded by hisDiscussion
The differential diagnosis of a yellowish conjunctival mass,
with or without limbal involvement, includes epibulbar
dermoid, dermolipoma, and, less frequently, phlyctenular
keratoconjunctivitis, neurofibroma, fibrous histiocytoma,
pterygium, pyogenic granuloma, and foreign body granu-
loma, as well as other primary and secondary inflammatory
lesions such as JXG and Langerhans cell histiocytosis [2].
Histopathologically, the typical findings of JXG include a
mixture of foamy and epitheloid histiocytes with scattered
lymphocytes, eosinophils, and plasma cells, and typical
Touton giant cells with wreath shaped nuclei [1]. Occa-
sionally, corneoscleral limbal JXG must be differentiated
from other, more severe conditions, such as Langerhans
cell histiocytosis [12]. Most JXG lesions are positive for
macrophage markers, such as CD 68 and HAM 56 [2,11],
but are negative for Langerhans cell markers, such as
S-100 and CD1a [13]. S-100, however, may be positive;
for example, a recent series found that 6 of 100 cutaneous
JXGs were positive for monoclonal markers of S-100
protein [14]. The yellowish subconjunctival lesion in our
patient was positive for CD68 but negative for S-100 and
CD1a, findings compatible with a diagnosis of JXG.
Cutaneous JXG usually improves spontaneously without
any treatment. Ocular lesions, however, rarely disappear
spontaneously and thus require treatment. Although there
is no standard treatment for ocular JXG, several modalitiesmixed inflammatory lesion composed of dense infiltrates of epithelioid
cleate giant cells (×100). (B) Multinucleate Touton giant cells with
tiocytes (×200).
Figure 3 Immunohistochemical stainings. Strong positive staining for the macrophage marker CD68 (A), and negative staining for the Langerhans
cell markers S-100 protein (B) and CD1a (C) (×100).
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steroid injection, cryotherapy, and low dose radiotherapy
[2,11,15]. Patients with lesions recurrent or resistant to
these treatments may be treated with systemic chemother-
apy [13,16]. In most previous patients, corneoscleral JXG
was not associated with any systemic xanthogranulo-
matous disease, suggesting that limbal JXG is a localized
disorder. Most patients with limbal JXG have been
successfully treated by simple excision, with or without
keratectomy and lamellar graft. Since the mass in our
patient did not involve the cornea, simple excision without
keratectomy was sufficient to control for recurrence.
The patient described here can be distinguished from
previous patients with ocular JXGs. To our knowledge,
our patient, at the age of 58, is the oldest reported to date
among patients with ocular JXGs [6-11]. In addition, this
is the second report of a rare solitary subconjunctival
JXG without limbal involvement. The first patient, a
43-year-old man, was treated with excision and additional
cyrotherapy without recurrence for 2 months [11]. By
contrast, our patient was successfully treated by simple
excision, without recurrence for 1 year.
Conclusion
JXG can occur as a solitary subconjunctival mass even in
older adults, and immunohistochemistry is useful in differ-
ential diagnosis. Simple excision with careful dissection
may be effective in treating a subconjunctival JXG.
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